Where clinical development, evidence and artificial intelligence meet.
Independent perspectives on how AI is reshaping pharmaceutical R&D, clinical development, CROs, regulation and the future of work.
Latest insights
- From Evidence to Decisions: How AI Can Help Pharma Reach Better Development Decisions EarlierA practical framework for reducing evidence and decision latency in pharmaceutical R&D—and for using AI, MIDD and governance to reach better development decisions earlier.
- AI Will Not Eliminate CROs. It Will Redefine What Clients Pay Them ForAI is changing CRO economics, research-site requirements, patient matching and trial execution. See where new value will emerge in clinical R&D.
- AI Will Turn Pharma into an Evidence IndustryAI is making drug candidates abundant. See how evidence, pipeline governance, M&A, human data and portfolio decisions will reshape Pharma R&D.
About Rafael
Rafael Ioschpe is a clinical development operations and portfolio leader with more than 20 years of experience across pharmaceutical, biotechnology and CRO organizations.